Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Henan Cancer Hospital
Baylor College of Medicine
Centre Antoine Lacassagne
Universität des Saarlandes
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
City of Hope Medical Center
Case Comprehensive Cancer Center
Gilead Sciences
National Cancer Institute (NCI)
Sunnybrook Health Sciences Centre
Mabion SA
University of Nebraska
Hoffmann-La Roche
University of Nebraska
Eastern Cooperative Oncology Group
Celgene
University College, London
National Institutes of Health Clinical Center (CC)
TCR2 Therapeutics
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
SWOG Cancer Research Network
Roswell Park Cancer Institute
Universität des Saarlandes
City of Hope Medical Center
Hoffmann-La Roche
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
SWOG Cancer Research Network
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Washington
M.D. Anderson Cancer Center
Celgene
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Kosin University Gospel Hospital
Roswell Park Cancer Institute